Invention relates to Ethosome compositions for transdermal drug delivery comprises therapeutically effective amount of curcumin, phospholipon 90H, cholesterol, propylene glycol and ethanol. The process comprises dissolving curcumin, cholesterol and phospholipon 90H in ethanol and propylene, addition of distilled water, cooling homogenisation to obtain the ethosome composition.

Patent Application Number: 1734/MUM/2011

For more details about technology: Click here

Invention relates to a process for detecting the presence or absence of human hemoglobin HbAO and/or HbE in a sample by way of nanoparticle -hemoglobin interaction. Process for detecting the presence or absence of human hemoglobin HbAO and/or HbE in a sample comprises treating sample with copper nanoparticle, formation of moderate precipitate or aggregate indicating the presence of human haemoglobin HbE and the process has diagnostic ability to differentiate among proteins by the extent of their unfolding.

Patent Application Number: 39/DEL/2011

For more details about technology: Click here

Invention relates to a process for preparation of nanocrystals of poorly water soluble drugs to increase the solubility and dissolution rate and bioavailability. It is an improved process for preparation of nanocrystals of lovastatin (LVS) to increase the solubility and dissolution rate and bioavailability. Lovastatin is a member of the drug class of statins, used for lowering cholesterol.

Patent Application Number: 1215/MUM/2011

For more details about technology:  Click here

Technology relates to an inexpensive and extremely effective synthetic lung surfactant, which has the potential to save the lives of babies, children and adults suffering with any of a range of respiratory and lung ailments. Synthetic formulation consisting of a combination of phospholipids and synthetic peptides which may be administered in liquid form or nebulised/aerosolised.

Patent Application Number:: WO2011/104621

For more details about technology: Click Here

Invention relates to the field of novel anticancer agents. Compounds shown in figure are useful for the treatment of cancer, AIDS, HIV infections and asthma.

Patent Application Number: 7332629

For more details about technology: Click Here

Technology relates to a Chemoenzymatic process for the stereoselective preparation of both (R) and (S) enantiomers of 3-hydroxy-3-phenylpropanenitrile, useful as a key intermediate for synthesis of (S)-Fluoxetine, (R)-Tomoxetine and cognant compounds.

Patent Application Number: WO/2002/057475, Granted Indian and UK Patent and pending JP Patent.

For more details about technology: Click Here